LGM Pharma Enters Consent Decree Following Allegations of Adulterated Drugs

By PacConAdmin | January 30, 2023

A federal court in Florida has issued a consent decree against LGM Pharma, a Boca Raton-based active pharmaceutical ingredient (API) importer and distributor, prohibiting the company from distributing APIs that don’t comply with current good manufacturing practices (cGMP).
Source: Drug Industry Daily

Posted in Drug Industry Daily